Discover comprehensive details about Tolperisone, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Tolperisone, a centrally-acting muscle relaxant, may treat symptoms of acute muscle spasms without the sleepiness and cognitive effects associated with other skeletal muscle relaxants, data from the ...

Tolperisone (Tolfree (100 mg)) is a muscle relaxant, prescribed for spasticity and muscle spasms. The information provided on this page is intended to serve as a comprehensive resource and should not ...

Wien (pta022/19.01.2017/11:09 UTC+1) Sanochemia announces advancement of Tolperisone's clinical development by Neurana Pharmaceuticals Inc. in the USA Vienna, January 19, 2017 - Sanochemia ...

SAN DIEGO, Dec. 8, 2020 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced positive top-line results from the Phase ...

SAN DIEGO, June 8, 2020 /PRNewswire/ -- Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that the first ...

SAN DIEGO, Oct. 5, 2012 /PRNewswire/ -- Katama Pharmaceuticals, a newly formed specialty pharmaceutical company, today announced the signing of an exclusive license agreement with Sanochemia ...

The Drugs Controller General (India) has directed the State drug controllers to restrict the fixed dose combination (FDC) tolperisone HCI 150 mg+ paracetamol IP 500 mg tablet only for symptomatic ...

SAN DIEGO, May 7, 2018 /PRNewswire/ -- Neurana Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the treatment of neuromuscular conditions, announced the completion of a $60 million ...

SAN DIEGO, Dec. 8, 2020 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced positive top-line results from the Phase ...